04/12/2024 3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/12/2024 3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 7:37 PM | Eagle Pharmaceuticals (Subject) Tarriff Scott (Filed by)
| Form SC 13G/A | |
03/18/2024 7:00 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-K | |
03/08/2024 3:49 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 3:40 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 6:35 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
02/29/2024 7:23 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:44 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 7:09 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 2:53 PM | Eagle Pharmaceuticals (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/13/2024 7:50 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 12:38 PM | BRANDES INVESTMENT PARTNERS, LP (Filed by) Eagle Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024 8:15 AM | Eagle Pharmaceuticals (Subject) HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
02/06/2024 4:09 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 1:04 PM | Eagle Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 5:56 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2024 6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 4:00 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 4:01 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 6:00 PM | Eagle Pharmaceuticals (Issuer) Graves Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:15 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K/A | |
12/20/2023 3:34 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 4:11 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 3:26 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2023 6:36 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2023 6:39 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 4:23 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
11/09/2023 6:57 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 3:39 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 4:41 PM | Eagle Pharmaceuticals (Issuer) Graves Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 7:49 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2023 6:10 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 4:07 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 3:48 PM | Eagle Pharmaceuticals (Subject) Tarriff Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023 6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 6:20 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/29/2023 5:55 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/17/2023 5:59 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 6:06 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2023 5:59 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Do This Today BEFORE Biden Wins in November (Ad) Discover "U.S.'s New Money" Before Biden Wins
A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it). Find out how you can too in this free video. |
07/24/2023 6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 7:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2023 5:57 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2023 7:43 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2023 7:23 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/18/2023 4:22 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 7:34 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 11:43 AM | Eagle Pharmaceuticals (Subject) Tarriff Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |